3D Global Biotech Inc. (TPEX:6808)
Taiwan · Delayed Price · Currency is TWD 47.80
+2.75 (6.10%)
At close: Dec 5, 2025
3D Global Biotech Market Cap
3D Global Biotech has a market cap or net worth of 3.72 billion as of December 5, 2025. Its market cap has increased by 29.01% in one year.
Market Cap
3.72B
Enterprise Value
3.04B
Revenue
324.87M
Ranking
n/a
PE Ratio
27.99
Stock Price
47.80
Market Cap Chart
Since December 25, 2020, 3D Global Biotech's market cap has increased from 2.74B to 3.72B, an increase of 35.98%. That is a compound annual growth rate of 6.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 3.72B | -27.48% |
| Dec 31, 2024 | 5.13B | 371.49% |
| Dec 29, 2023 | 1.09B | -27.35% |
| Dec 30, 2022 | 1.50B | -30.09% |
| Dec 30, 2021 | 2.14B | -18.98% |
| Dec 31, 2020 | 2.64B | -3.35% |
| Dec 25, 2020 | 2.74B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 258.22B |
| PharmaEssentia | 191.95B |
| Lotus Pharmaceutical | 78.89B |
| Bora Pharmaceuticals Co., LTD. | 65.31B |
| Lin BioScience | 33.46B |
| Oneness Biotech | 32.96B |
| Lumosa Therapeutics | 32.77B |
| Center Laboratories | 27.88B |